Trials / Sponsors / Pharnext S.C.A.
Pharnext S.C.A.
Academic / Other · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients Charcot-Marie-Tooth Disease | Phase 3 | 2021-03-30 |
| Unknown | Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A Charcot-Marie-Tooth Disease, Type IA | Phase 3 | 2017-03-07 |
| Completed | Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) Charcot-Marie-Tooth Disease Type 1A | Phase 3 | 2015-12-01 |
| Completed | 24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Comple Alzheimer Disease | Phase 2 | 2013-06-01 |
| Completed | Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) Alzheimer Disease | Phase 2 | 2013-02-01 |
| Completed | Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Charcot-Marie-Tooth Disease, Hereditary Neuropathy With Liability to Pressure Palsies, Genetic Disorders | Phase 2 | 2010-12-01 |